Approval · Notice of Compliance 14841 · 2013
REACTINE COMPLETE: Notice of Compliance 14841
Issued October 22, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14841
- Date
- October 22, 2013
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product name change
- Therapeutic class
- Histamine h1-receptor antagonist; sympathomimetic amine
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE COMPLETE | 02246162 | Marketed |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 5 MG per TAB
- PSEUDOEPHEDRINE HCL 120 MG per TAB